The REPROCELL group has signed a non-exclusive distributorship agreement with RUITAI Biotechnology (Shanghai) Ltd to distribute REPROCELL’s products in China.
Funding will be used to improve efficiency of induced pluripotent stem cell production
REPROCELL Europe’s CEO, Dr David Bunton, was part of last week's trade mission to China undertaken by the Scottish First Minister, the Rt. Hon. Nicola Sturgeon MSP.
REPROCELL Europe Ltd was pleased to receive a visit from Derek Mackay, the Scottish National Party’s Cabinet Secretary for Finance and the Constitution, on 05 April 2017.
PALO ALTO, CA, November 8, 2017 – Science Exchange, the world’s leading and most secure enterprise platform for outsourced research services and procurement of human biospecimens, announced today that REPROCELL has selected the Science Exchange platform as the primary marketplace to offer access to its predictive drug discovery assays for the biopharma research community.
REPROCELL Inc. (Japan)’s CEO Dr Chikafumi Yokoyama had the honour of meeting with Fiona Hyslop, Cabinet Secretary for Culture, Tourism and External Affairs for the Scottish Government, during her visit to the Scottish Enterprise Tokyo office, today (14 February 2017).
Scotland’s Life Sciences Dinner was held on 2nd February 2017 at the National Museum of Scotland. The event was attended by CEO and Chairman of REPROCELL Inc, Dr Chikafumi Yokoyama, as well as senior management members of REPROCELL Europe Ltd, to join and celebrate the outstanding achievements of the Life Sciences sector in Scotland over the past year amongst over 800 guests.